Found 8 results
Name | Type of Offering | Accepted Date |
---|---|---|
PhaseBio Pharmaceuticals Inc
|
D | 2009-11-11 |
Amount To Be Raised
$1,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-09-000004
Exclusions or Exemptions
N/A
Accepted Date
2009-11-11
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NORTH CAROLINA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PhaseBio Pharmaceuticals Inc
|
D/A | 2012-06-15 |
Amount To Be Raised
$48,524,067
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-12-000001
Exclusions or Exemptions
N/A
Accepted Date
2012-06-15
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PhaseBio Pharmaceuticals Inc
|
D | 2010-01-04 |
Amount To Be Raised
$25,300,001
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-10-000001
Exclusions or Exemptions
N/A
Accepted Date
2010-01-04
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
NORTH CAROLINA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PhaseBio Pharmaceuticals Inc
|
D | 2015-03-10 |
Amount To Be Raised
$40,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-15-000001
Exclusions or Exemptions
506b
Accepted Date
2015-03-10
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PhaseBio Pharmaceuticals Inc
|
D | 2017-01-31 15:53:28 |
Amount To Be Raised
$7,875,000
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-17-000002
Exclusions or Exemptions
506b
Accepted Date
2017-01-31 15:53:28
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
PhaseBio Pharmaceuticals Inc
|
D/A | 2010-12-02 |
Amount To Be Raised
$25,300,001
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-10-000002
Exclusions or Exemptions
N/A
Accepted Date
2010-12-02
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PhaseBio Pharmaceuticals Inc
|
D/A | 2015-07-21 |
Amount To Be Raised
$42,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-15-000002
Exclusions or Exemptions
506b
Accepted Date
2015-07-21
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
PhaseBio Pharmaceuticals Inc
|
D | 2018-09-07 18:02:30 |
Amount To Be Raised
$32,125,000
Associated Brokers / Dealers
N/A
CIK Number
0001169245
Filed Document
0001169245-18-000001
Exclusions or Exemptions
506b
Accepted Date
2018-09-07 18:02:30
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
PENNSYLVANIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|